現貨鈀金日內大漲6.00%，現報1427.25美元/盎司。

September 4 — Merck said China’s NMPA approved its PD‑1 inhibitor pembrolizumab for adults with resectable locally advanced head‑and‑neck squamous cell carcinoma whose tumors express PD‑L1 (combined positive score CPS ≥1) by a validated test. Approval covers single‑agent neoadjuvant use, postoperative adjuvant radiotherapy with or without cisplatin, and continued pembrolizumab monotherapy thereafter.

美聯儲理事沃勒：抵押貸款利率和汽車貸款利率並不低。